Spatial distribution of metals in the constructed wetlands

Investigation of the spatial distribution of metals was conducted for two constructed wetlands used as tertiary treatment in Chia Nan University of Pharmacy and Science (CNU) and Metal Processing Industries (MPI) located in Tainan, Taiwan. These two distinguished sites were selected to compare the distribution of metals for constructed wetlands treating different types of wastewater. Along the distance, samples of water, sediment, and macrophytes were analyzed for metals including Al, Cd, Cr, Cu, Fe, Mn, Ni, Pb, and Zn. Additionally, measurements of water quality including temperature, pH, EC, ORP, DO, TSS, BOD, COD, and turbidity were performed. Results show that, at CNU, wastewater contained higher organic consititute (BOD 29.3 +/- 11.7 mg/, COD 46.7 +/- 33.6 mg/L) with low metals content. Wastewater at MPI contained low level of organic consititute (BOD 7.1 +/- 3.3 mg/L, and COD 66.0 +/- 56.5 mg/L) and higher metals content. Metals distribution of both sites showed similar results where metals in the sediments in the inlet zone have greater concentrations than other areas. The constructed wetlands can remove Cd, Cu, Ni, Pb, and Zn. However, there was no removal of Al, Cr, Fe, and Mn. A distance along the constructed wetlands had no effect on metal concentrations in macrophyte and water.     

Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus

The immunomodulatory role of 1,25-dihydroxyvitamin D3 is well known. An association between vitamin D receptor (VDR) gene BsmI polymorphisms and systemic lupus erythematosus (SLE) has been reported. To examine the characteristics of VDR gene BsmI polymorphisms in patients with SLE and the relationship of polymorphisms to the susceptibility and clinical manifestations of SLE, VDR genotypings of 101 Thai patients with SLE and 194 healthy controls were performed based on polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The relationship between VDR gene BsmI polymorphisms and clinical manifestations of SLE was evaluated. The distribution of VDR genotyping in patients with SLE was 1.9% for BB (non-excisable allele homozygote), 21.78% for Bb (heterozygote), and 76.23% for bb (excisable allele homozygote). The distribution of VDR genotyping in the control group was 1.03% for BB, 15.98% for Bb, and 82.99% for bb. There was no statistically significant difference between the two groups (p = 0.357). The allelic distribution of B and b was similar within the groups (p = 0.173). The relationship between VDR genotype and clinical manifestation or laboratory profiles of SLE also cannot be statistically demonstrated. In conclusion, we cannot verify any association between VDR gene BsmI polymorphism and SLE. A larger study examining other VDR gene polymorphisms is proposed.